ProShares Ultra Nasdaq Biotechnology (BIB)

Add to Watchlists
Create an Alert
59.94 -1.60  -2.60% NASDAQ Jan 16, 16:59 Delayed 2m USD
View Full Chart
BIB Price Chart

BIB Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 11.91% 12.10% -- --
3M -1.52% -1.35% -- --
6M 12.32% 12.55% -- --
YTD 9.76% 9.88% -- --
1Y 39.99% 39.93% -- --
3Y -2.96% -2.94% -- --
5Y 30.55% 30.53% -- --
10Y -- -- -- --
As of Jan. 12, 2018. Returns for periods of 1 year and above are annualized.

BIB Asset Allocation

Type % Net % Long % Short
Cash -97.40% 19.50% 116.9%
Stock 97.39% 97.39% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 100.0% 103.1% 3.09%
As of Dec. 31, 2017
View More Holdings

BIB Top 10 Holdings

Symbol Name % Weight Price % Chg
-- Nasdaq Biotechnology Index Swap Bank Of America Na 26.42% -- --
-- Ishares Biotech (Ibb) Swap Bank Of America Na 19.69% -- --
-- Nasdaq Biotechnology Index Swap Societe Generale 19.35% -- --
-- Nasdaq Biotechnology Index Swap Deutsche Bank Ag 16.89% -- --
-- Nasdaq Biotechnology Index Swap Credit Suisse International 15.78% -- --
-- Nasdaq Biotechnology Index Swap Ubs Ag 8.93% -- --
CELG Celgene Corp 6.56% 104.00 -1.89%
AMGN Amgen Inc 6.27% 185.66 +0.34%
BIIB Biogen Inc 6.27% 338.80 +0.85%
GILD Gilead Sciences Inc 6.07% 80.24 +1.54%
As of Dec. 31, 2017
Advertisement

BIB Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Alternative
Broad Category Alternative
Category Name Trading--Leveraged Equity
Prospectus Objective Specialty - Technology
Fund Owner Firm Name ProShares
Benchmark Index
NASDAQ Biotechnology TR USD
200.0%

BIB Manager Info

Name Tenure
Devin Sullivan 1.09 yrs
Michael Neches 4.09 yrs

BIB Net Fund Flows

1M -30.69M
3M -10.43M
6M 29.60M
YTD -109.28M
1Y -109.28M
3Y 17.88M
5Y 272.21M
10Y --
As of Dec. 31, 2017

BIB Risk Info

Beta (5Y) 2.452
Max Drawdown (All) 67.24%
Historical Sharpe (10Y) --
Historical Sortino (All) 1.347
30-Day Rolling Volatility 32.75%
Daily Value at Risk (VaR) 1% (All) 8.15%
Monthly Value at Risk (VaR) 1% (All) 32.17%

BIB Comparables

Edit

BIB Attributes

Key Dates
Inception Date 4/6/2010
Termination Date
Last Annual Report Date 5/31/2017
Last Prospectus Date 10/1/2017
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

BIB Excel Add-In Codes

  • Name: =YCI("BIB","name")
  • Broad Asset Class: =YCI("BIB", "broad_asset_class")
  • Broad Category: =YCI("BIB", "broad_category_group")
  • Prospectus Objective: =YCI("BIB", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.